About This EventAdamas Trust, Inc. (Nasdaq: ADAM), visits the Nasdaq MarketSite in Times Square. Adamas Trust is an ...
Palantir Technologies Inc. Class A Common Stock is expected* to report earnings on 02/02/2026 after market close. The report will be for the fiscal Quarter ending Dec 2025. According to Zacks ...
Nasdaq net revenues crossed the $5 billion mark for the first time in 2025 as both top-line and bottom-line metrics saw strong growth. The company reported its fourth quarter and ...
About This EventThe Fashion Foundation, a New York based 501c3 charity that recycles designer fashion samples while providing school supplies to local kids in need, visits the Nasdaq MarketSite in ...
About This EventAtlas Critical Minerals Corporation (Nasdaq: ATCX) is an exploration and development company focused on critical minerals, including rare earths, graphite, and uranium. The Company's ...
While annual reports are clearly the most comprehensive, 10-Qs and 6-Ks can also include some of the items marked with a red “X” if there is a material development for the company triggering ...
About This EventEthos (Nasdaq: LIFE), a leading life insurance technology company on a mission to democratize access to life insurance visits the Nasdaq MarketSite in Times Square.In honor of the ...
The Securities and Exchange Commission recently approved a Nasdaq proposal that will give options traders more flexibility and control over their investments on Qualifying Securities. David Barrett, ...
Western Digital Corporation Common Stock is expected* to report earnings on 01/29/2026 after market close. The report will be for the fiscal Quarter ending Dec 2025. According to Zacks Investment ...
About This EventAmerica Needs You (ANY), a national nonprofit connecting ambitious, first-generation college students with transformative mentorship and intensive career development for economic ...
About This EventLexicon Pharmaceuticals (Nasdaq: LXRX), a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives, visits the Nasdaq MarketSite in Times Square ...
About This EventMaze Therapeutics (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with kidney and metabolic diseases, visits the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results